Solengepras shows strong potential as an adjunctive therapy for Parkinson’s, offering a novel, well-tolerated option with ...

The act of ordering a coffee a dopaminergic reward system, while even the anticipation of waiting for a coffee or a tea can ...

Researchers have successfully developed nerve grafts, currently being trialed as a treatment for Parkinson’s disease, that ...

Members of the Our Place Parkinson’s support group learned about a newly approved therapy offering more consistent symptom ...

See α-Synuclein. Candidate tracer SY08 detects α-synuclein deposits in the brainstem (right) and parietal cortex (left) of people with Parkinson’s (middle) and dementia with Lewy bodies (bottom), but ...

A recent study from INL successfully combined two cutting-edge 3D tissue engineering technologies - 3D polymeric scaffolds and 3D neuronal spheroids - to develop a highly advanced model for ...

How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, ...

CVN293 was generally well-tolerated in healthy volunteers with evidence of robust brain penetration, supporting utility of KCNK13 inhibitors for ...

A leading neurologist shares the science of how the ritual of ordering a coffee can make us happier and more motivated before even taking the ...

Solengepras showed evidence of potential benefit in functional and non-motor symptoms versus placebo as measured by MDS-UPRDS Parts I, II, NMSS, and ESS, consistent with its novel non-dopaminergic ...

In connection with the financing, Serina issued 965,250 shares of convertible preferred stock at $5.18 per share, equivalent to the closing price of its common stock on April 7, 2025.